Full steam ahead for new hospital-led generics venture

Civica Rx, a US-based generics company founded by a group of hospitals, has recruited another 12 health systems to its founding membership, representing approximately 250 hospitals.

The company, which  appointed former Amgen (Nasdaq: AMGN) chief quality officer Martin VanTrieste as chief executive last year, now counts over 750 US hospitals among its members, and it says many more health systems have expressed interest.

In early 2018, three philanthropies and seven leading health systems joined forces to start the company, with the intention of “helping patients by addressing the often unwarranted shortages and high costs of lifesaving generic medications."